Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5AN1 Inhibitors

The olfactory receptor OR5AN1 is a G protein-coupled receptor engaged in the molecular detection of odor molecules. As part of the intricate olfactory system, OR5AN1 contributes to the complex process of odor identification and perception. The expression of OR5AN1, like that of other olfactory receptors, is tightly controlled by various cellular mechanisms that include transcription factors, epigenetic modifications, and intricate signaling pathways. Understanding how the expression of OR5AN1 can be inhibited is of interest from a biological perspective, as it offers insight into the regulation of olfactory receptors and the broader implications for sensory function. Inhibitors that can decrease the expression of OR5AN1 operate at different cellular levels, from direct DNA interaction to the modulation of signaling pathways that govern gene expression. Research into the inhibition of OR5AN1 expression encompasses compounds that interact with the DNA structure or the transcriptional machinery itself. Actinomycin D, for example, is known to intercalate into DNA, potentially blocking transcriptional processes by hindering the advancement of RNA polymerase along the DNA template. Histone deacetylase inhibitors, such as Trichostatin A, could lead to changes in chromatin structure around the OR5AN1 gene, creating a less permissive environment for transcription. Compounds like 5-Azacytidine can be incorporated into the gene sequence, inducing epigenetic changes that may result in decreased expression. On another level, signal transduction inhibitors such as LY294002 or PD98059 specifically target kinases within cellular pathways that are crucial for the expression of many genes, including OR5AN1. These substances can downregulate gene expression by disrupting the normal cascade of signaling events that lead to the activation of transcription factors and the initiation of mRNA synthesis. While the direct effects of these inhibitors on OR5AN1 have not been conclusively demonstrated, the mechanisms they target provide a basis for the modulation of gene expression. Understanding these processes contributes to our knowledge of gene regulation and the complex molecular choreography that underlies cellular function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D could intercalate between guanine and cytosine bases of DNA, potentially downregulating OR5AN1 by obstructing the transcription initiation complex, thereby preventing RNA polymerase from transcribing the gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine, once incorporated into the OR5AN1 gene sequence, may induce hypomethylation, which could lead to the repression of gene expression through epigenetic remodeling.

Mithramycin A

18378-89-7sc-200909
1 mg
$54.00
6
(1)

By selectively binding to GC-rich DNA sequences, Mithramycin A might competitively inhibit the binding of transcription factors necessary for OR5AN1 expression, leading to a decrease in its mRNA synthesis.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide may inhibit the transcription of OR5AN1 by suppressing the activity of transcription factors or by directly interacting with the transcriptional machinery, thereby leading to reduced mRNA levels.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

As a histone deacetylase inhibitor, Trichostatin A could increase the acetylation of histones near the OR5AN1 gene, which might result in a condensed chromatin state and a subsequent decrease in gene expression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine could intercalate into the DNA helix, potentially obstructing RNA polymerase movement along the OR5AN1 gene sequence and thus reducing transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin could inhibit the mTOR signaling pathway, which may be essential for the transcriptional machinery assembly at the OR5AN1 promoter site, leading to decreased expression of the gene.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002, by inhibiting PI3K, may disrupt downstream AKT signaling and thus could lead to suppression of transcription factors that are crucial for OR5AN1 expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059, an MEK inhibitor, could impede the ERK pathway, potentially leading to the downregulation of transcription factors responsible for the normal expression of OR5AN1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK inhibitor, SP600125 could decrease the activity of AP-1 transcription factor, which may be involved in the upstream regulation of OR5AN1, resulting in diminished expression.